Global Digital PCR (d-PCR) Market

Focus on Product-Type, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2020-2025

Published Year: 2020
SKU: BHP0944SA

5000

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Product Definition

1.1    Definition by Product
         1.1.1    Platforms
         1.1.2    Assays and Reagents
         1.1.3    Accessories and Instruments
1.2    Inclusion and Exclusion
1.3    Scope of Work
1.4    Key Questions Answered in the Report

2 Research Methodology

2.1    Primary Data Sources
2.2    Secondary Data Sources
2.3    Market Estimation Model
2.4    Criteria for Company Profiling

3 Market Overview

3.1    Digital PCR: A Next-Generation PCR Technology
3.2    Digital PCR(d-PCR) vs. Quantitative PCR (q-PCR)
3.3    COVID-19 Impact on Digital PCR (d-PCR)
3.4    Digital PCR Clinical Trials

4 Global Digital PCR (d-PCR) Market Dynamics

4.1    Overview
4.2    Impact Analysis
4.3    Market Drivers
         4.3.1    Rising Incidence of Infectious Disease, such as recent pandemic COVID-19, Inciting the Development of High-throughput Diagnostics    
         4.3.2    Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer    
         4.3.3    Significant External Funding for Executing Research & Development Exercises
4.4    Market Restraints
         4.4.1    Shortage of Skilled Professionals and Trained Lab-Technicians    
         4.4.2    High Cost of Platforms Associated with Digital-PCR
4.5    Market Opportunities
         4.5.1    Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
         4.5.2    Technological Advancements in the Development of Digital-PCR Based Solutions    
         4.5.3    Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan

5 Competitive Landscape

5.1    Key Strategies and Developments
         5.1.1    Product Approvals
         5.1.2    Product Launches and Upgradations
         5.1.3    Synergistic Activities
         5.1.4    Funding and Expansion
         5.1.5    Mergers and Acquisitions
5.2    Patent Analysis
5.3    Market Share Analysis (by Company) 2019
5.4    Growth Share Analysis (Opportunity Mapping)
         5.4.1    By Company
5.5    Regulatory Framework
         5.5.1    Legal Requirements and Framework in the U.S.
         5.5.2    Legal Requirements and Framework in Europe
         5.5.3    Legal Requirements and Framework in Asia-Pacific
                     5.5.3.1    China
                     5.5.3.2    Japan

6 Global Digital PCR (d-PCR) Market, by Product $Million, 2019-2025

6.1    Introduction
6.2    Assays and Reagents
6.3    Platforms
         6.3.1    Droplet-Based Digital PCR (d-PCR)
         6.3.2    Chip-Based Digital PCR (d-PCR)
6.4    Accessories and Instruments

7 Global Digital PCR (d-PCR) Market (by Application) $Million, 2019-2025

7.1    Clinical
         7.1.1    Oncology
         7.1.2    Non-Oncology
                     7.1.2.1    Infectious Disease
                     7.1.2.2    Non-Invasive Prenatal Testing (NIPT)
                     7.1.2.3    Forensics
7.2    Environmental Monitoring
7.3    Food and Agriculture
7.4    Other Applications

8 Digital PCR (d-PCR) Market (by End User), 2019-2025

8.1    Overview
8.2    Hospitals and Clinics
8.3    Academic and Research Institutions
8.4    Diagnostic Centers
8.5    Other End Users

9 Global Digital PCR (d-PCR) Market (by Region), 2019-2025

9.1    Overview
9.2    North America
         9.2.1    U.S.
         9.2.2    Canada
9.3    Europe
         9.3.1    Germany
         9.3.2    U.K.
         9.3.3    France
         9.3.4    Italy
         9.3.5    Spain
         9.3.6    Rest-of-Europe
9.4    Asia-Pacific
         9.4.1    China
         9.4.2    Japan
         9.4.3    India
         9.4.4    Australia
         9.4.5    Singapore
         9.4.6    Rest-of-APAC
9.5    Latin America
         9.5.1    Brazil
         9.5.2    Mexico
         9.5.3    Rest-of-Latin America
9.6    Rest-of-the-World

10 Company Profiles

10.1    Overview
10.2    Bio-Rad Laboratories, Inc.
           10.2.1    Company Overview
           10.2.2    Role of Bio-Rad Laboratories, Inc. in Global Digital PCR Market    
           10.2.3    Financials
           10.2.4    Key Insights About Financial Health of the Company
           10.2.5    SWOT Analysis
10.3    Combinati
           10.3.1    Company Overview
           10.3.2    Role of Combinati in Global Digital PCR Market
           10.3.3    SWOT Analysis
10.4    Dropworks, Inc.
           10.4.1    Company Overview
           10.4.2    Role of Dropworks, Inc. in Global Digital PCR Market
10.5    Fluidigm Corporation
           10.5.1    Company Overview
           10.5.2    Role of Fluidigm Corporation in Global Digital PCR Market
           10.5.3    Financials
           10.5.4    Key Insights About Financial Health of the Company
           10.5.5    SWOT Analysis
10.6    Genetron Holdings Limited
           10.6.1    Company Overview
           10.6.2    Role of Genetron Holdings Limited in Global Digital PCR Market    
           10.6.3    Financials
           10.6.4    Key Insights About Financial Health of the Company
           10.6.5    SWOT Analysis
10.7    JN Medsys
           10.7.1    Company Overview
           10.7.2    Role of JN Medsys in Global Digital PCR Market
           10.7.3    SWOT Analysis
10.8    Merck KGaA
           10.8.1    Company Overview
           10.8.2    Role of Merck KGaA in Global Digital PCR Market
           10.8.3    Financials
           10.8.4    Key Insights About Financial Health of the Company
           10.8.5    SWOT Analysis
10.9    Naveris, Inc.
           10.9.1    Company Overview
           10.9.2    Role of Naveris, Inc. in Global Digital PCR Market
           10.9.3    SWOT Analysis
10.10    OPTOLANE Technologies Inc.
             10.10.1    Company Overview
             10.10.2    Role of OPTOLANE Technologies in Global Digital PCR Market    
             10.10.3    SWOT Analysis
10.11    QIAGEN N.V.
             10.11.1    Company Overview
             10.11.2    Role of QIAGEN N.V. in Global Digital PCR Market
             10.11.3    Financials
             10.11.4    Key Insights About Financial Health of the Company
             10.11.5    SWOT Analysis
10.13    Saga Diagnostics AB
             10.13.1    Company Overview
             10.13.2    Role of Saga Diagnostics AB in Global Digital PCR Market
             10.13.3    SWOT Analysis
10.14    Stem Genomics
             10.14.1    Company Overview
             10.14.2    Role of Stem Genomics in Global Digital PCR Market
             10.14.3    SWOT Analysis
10.15    Sysmex Corporation
             10.15.1    Company Overview
             10.15.2    Role of Sysmex Corporation in Global Digital PCR Market
             10.15.3    Financials
             10.15.4    Key Insights About Financial Health of the Company
             10.15.5    SWOT Analysis
10.16    Stilla Technologies Inc.
             10.16.1    Company Overview
             10.16.2    Role of Stilla Technologies Inc. in Global Digital PCR Market
             10.16.3    SWOT Analysis
10.17    Thermo Fisher Scientific Inc.
             10.17.1    Company Overview
             10.17.2    Role of Thermo Fisher Scientific Inc. in Global Digital PCR Market
             10.17.3    Financials
             10.17.4    Key Insights About Financial Health of the Company
             10.17.5    SWOT Analysis

List of Tables

Table 3.1:    Digital PCR(d-PCR) vs. Quantitative PCR (q-PCR)
Table 3.2:    Digital PCR (d-PCR) Diagnostics Solutions Offered for COVID-19
Table 3.3:    Digital PCR (d-PCR) Clinical Trials
Table 4.1:    Likert Scale
Table 4.2:    Impact Analysis of Market Drivers
Table 4.3:    Impact Analysis of Market Restraints
Table 4.4:    Funding Allocated for Precision Medicine to Different Agencies in U.S.
Table 4.5:    Funding for the Development of Digital PCR-based Diagnostics
Table 4.6:    Cost for Different Commercialized Digital PCR (d-PCR) Platforms
Table 5.1:    Global Digital PCR (d-PCR) Patents 2016-2020
Table 5.2:    Classification Rules of IVDs Under the IVDR
Table 5.3:    Registration Criteria for IVD Medical Devices as per the CFDA
Table 6.1:    Market Available Digital PCR (d-PCR) Assay and Reagents
Table 6.2:    Market Available Digital PCR (d-PCR) Platforms
Table 6.3:    Market Available Digital PCR (d-PCR) Accessories and Instruments

List of Figures

Figure 1:    Total Global Disease Burden (by Cause), 2017
Figure 2:    Impact Analysis of Market Drivers and Market Challenges on the Global Digital PCR (d-PCR) Market
Figure 3:    Global Digital PCR (d-PCR) Market (by Product Type) $Million, 2020 vs. 2025
Figure 4:    Global Digital-PCR (d-PCR) Market (by Application) $Million, 2020 vs. 2025
Figure 5:    Digital PCR (d-PCR) Market (by End User) $Million, 2020 vs. 2025
Figure 6:    Global Digital-PCR (d-PCR) Market Snapshot
Figure 1.1:    Global Digital-PCR (d-PCR) Market Segments
Figure 2.1:    Primary Research Methodology
Figure 3.1:    Working of Digital PCR
Figure 3.2:    Evolution of Digital PCR
Figure 4.1:    New Cases of Respiratory and Enteric Infections, Globally, 2012-2017
Figure 4.2:    Benefits of Multiplexing Infectious Disease Rapid Diagnostic Testing
Figure 5.1:    Share of Key Developments and Strategies, 2017-2020
Figure 5.2:    Product Launch and Upgradation Share (by Company), 2017-2020
Figure 5.3:    Synergistic Activities Share (by Company), 2017-2020
Figure 5.4:    Funding and Expansion Share (by Company), 2017–2020
Figure 5.5:    Market Share Analysis for the Global Digital PCR (d-PCR) Market, 2019
Figure 5.6:    Growth Share Matrix for Global Digital PCR (d-PCR) Market (by company), 2019
Figure 5.7:    Components Considered for Clinical Evidence as per the IVDR
Figure 5.8:    Process for Medical Device Designation by The MHLW and PDMA72
Figure 6.1:    Digital PCR (d-PCR) Market (by Product Type) $Million, 2019-2025
Figure 6.2:    Global Digital PCR (d-PCR) Market (Assays and Reagents) $Million, 2019-2025
Figure 6.3:    Digital PCR (d-PCR) Market (Platforms), 2019-2025 ($Millions)
Figure 6.4:    Digital PCR (d-PCR) Market (Droplet-Based), 2019-2025 ($Millions)
Figure 6.5:    Digital PCR (d-PCR) Market (Chip-Based), 2019-2025 ($Millions)
Figure 6.6:    Digital PCR (d-PCR) Market (Accessories and Instruments), 2019-2025 ($ Million)
Figure 7.1:    Global Digital PCR (d-PCR) Market (by Application) $Million, 2019-2025
Figure 7.2:    Global Digital PCR (d-PCR) Market (by Clinical Application) $Million, 2019-2025
Figure 7.3:    Digital PCR (d-PCR) Market (Oncology) $Million, 2019-2025
Figure 7.4:    Digital PCR (d-PCR) Application Market (Non-Oncology) $Million, 2019-2025
Figure 7.5:    Digital PCR (d-PCR) Non-Oncology Market (by Type) $Million, 2019-2025
Figure 7.6:    Digital PCR (d-PCR) Market (by Infectious Disease) $Million, 2019-2025
Figure 7.7:    Digital PCR (d-PCR) Market (by NIPT) $Million, 2019-2025
Figure 7.8:    Digital PCR (d-PCR) Market (by Forensics) $Million, 2019-2025
Figure 7.9:    Digital PCR (d-PCR) Market (Environmental Monitoring) $Million, 2019-2025
Figure 7.10:    Digital PCR (d-PCR) Market (Food and Agriculture) $Million, 2019-2025
Figure 7.11:    Digital PCR (d-PCR) Market (Other Application) $Million, 2019-2025
Figure 8.1:    Global Digital PCR (d-PCR) Market $Million, by End User, 2019-2025
Figure 8.2:    Global Digital PCR (d-PCR) Market (Hospitals and Clinics) $Million, 2019-2025
Figure 8.3:    Global Digital PCR (d-PCR) Market (by Academic and Research Institutions),  2019-2025
Figure 8.4:    Global Digital PCR (d-PCR) Market (Diagnostic Centers) $Million, 2019-2025
Figure 8.5:    Global Digital PCR (d-PCR) Market (by Other End-User) $Million, 2019-2025
Figure 9.1:    Global Digital PCR (d-PCR) Market (by Region) $Million, 2020 and 2025
Figure 9.2:    Global Digital PCR (d-PCR) Market (by Region) $Million, 2019-2025
Figure 9.3:    North America: Market Dynamics
Figure 9.4:    North America Digital PCR (d-PCR) $Million, 2019-2025
Figure 9.5:    North America Digital PCR (d-PCR) (by Country) $Million, 2019-2025
Figure 9.6:    U.S.  Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.7:    Canada Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.8:    Europe: Market Dynamics
Figure 9.9:    Europe Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.10:    Europe Digital PCR (d-PCR) Market (by Country) $Million, 2019-2025
Figure 9.11:    Germany Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.12:    U.K. Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.13:    France Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.14:    Italy Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.15:    Spain Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.16:    Rest-of-Europe Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.17:    APAC: Market Dynamics
Figure 9.18:    Asia-Pacific Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.19:    APAC Digital PCR (d-PCR) market (by Country) $Million, 2019-2025
Figure 9.20:    China Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.21:    Japan Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.22:    India Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.23:    Australia Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.24:    Singapore Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.25:    RoAPAC Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 8.26:    Latin America: Market Dynamics
Figure 9.27:    Latin America Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.28:    Latin America Digital PCR (d-PCR) Market (by Country) $Million, 2019-2025
Figure 9.29:    Brazil Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.30:    Mexico Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.31:    Rest-of-Latin America Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.32:    RoW Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 10.1:    Total Number of Companies Profiled
Figure 10.2:    Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 10.3:    Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
Figure 10.4:    Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
Figure 10.5:    Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
Figure 10.6:    Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
Figure 10.7:    Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 10.8:    Combinati: Product Portfolio
Figure 10.9:    Combinati: SWOT Analysis
Figure 10.10:    Dropworks, Inc.: Product Portfolio
Figure 10.11:    Fluidigm Corporation: Product Portfolio
Figure 10.12:    Fluidigm Corporation: Overall Financials, 2017-2019
Figure 10.13:    Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
Figure 10.14:    Fluidigm Corporation.: Revenue (by Region), 2017-2019
Figure 10.15:    Fluidigm Corporation: R&D Expenditure, 2017-2019
Figure 10.16:    Fluidigm Corporation: SWOT Analysis
Figure 10.17:    Genetron Holdings Limited: Product Portfolio
Figure 10.18:    Genetron Holdings Limited: Overall Financials, 2017-2019
Figure 10.19:    Genetron Holdings Limited: Revenue (by Business Segment), 2017-2019
Figure 10.20:    Genetron Holdings Limited: R&D Expenditure (2017-2019)
Figure 10.21:    Genetron Holdings Limited: SWOT Analysis
Figure 10.22:    JN Medsys: Product Portfolio
Figure 10.23    JN Medsys: SWOT Analysis
Figure 10.24:    Merck KGaA: Product Portfolio
Figure 10.25:    Merck KGaA: Overall Financials, 2017-2019
Figure 10.26:    Merck KGaA: Revenue (by Segment), 2017-2019
Figure 10.27:    Merck KGaA: Revenue (by Region), 2017-2019
Figure 10.28:    Merck KGaA: R&D Expenditure, 2017-2019
Figure 10.29:    Merck KGaA: SWOT Analysis
Figure 10.30:    Naveris, Inc.: Product Portfolio
Figure 10.31:    Naveris, Inc.: SWOT Analysis
Figure 10.32:    OPTOLANE Technologies Inc.: Product Portfolio
Figure 10.33:    OPTOLANE Technologies Inc.: SWOT Analysis
Figure 10.34:    QIAGEN N.V.: Product Offerings
Figure 10.35:    QIAGEN N.V.: Overall Financials, 2017-2019
Figure 10.36:    QIAGEN N.V.: Revenue (by Segment) $Million, 2017-2019
Figure 10.37:    QIAGEN N.V.: Revenue (by Region), 2017-2019
Figure 10.38:    QIAGEN N.V.: R&D Expenditure, 2017-2019
Figure 10.39:    QIAGEN N.V.: SWOT Analysis
Figure 10.40:    SAGA Diagnostics AB: Product Portfolio
Figure 10.41:    SAGA Diagnostics AB: SWOT Analysis
Figure 10.42:    Stem Genomics: Product Portfolio
Figure 10.43:    Stem Genomics: SWOT Analysis
Figure 10.44:    Sysmex Corporation: Overall Product Portfolio
Figure 10.45:    Sysmex Corporation: Overall Financials, 2017-2019
Figure 10.46:    Sysmex Corporation: Sales (by Segment), 2017-2019
Figure 10.47:    Sysmex Corporation: Sales (by Region), 2017-2019
Figure 10.48:    Sysmex Corporation: Research and Development Expenditure, 2017-2019
Figure 10.49:    Sysmex Corporation: SWOT Analysis
Figure 10.50:    Stilla Technologies Inc.: Product Portfolio
Figure 10.51:    Stilla Technologies Inc.: SWOT Analysis
Figure 10.52:    Thermo Fisher Scientific Inc.: Product Portfolio
Figure 10.53:    Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
Figure 10.54:    Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2017-2019
Figure 10.55:    Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
Figure 10.56:    Thermo Fisher Scientific Inc.: R&D Expenditure (2017-2019)
Figure 10.57:    Thermo Fisher Scientific Inc.: SWOT Analysis

You may also like

Published Year: 2021

Global Rare Disease Diagnostics Market: Focus on Disease, Trait Type, Products, Age Group, Test Type

The global rare disease diagnostics market has been currently witnessing a rapid growth and is...

 
Published Year: 2020

Global Infectious Disease Rapid Diagnostic Testing Market: Focus on Product, Disease, Technology, Ap

The global market for infectious disease rapid diagnostics is predicted to grow at a CAGR of...

 
Published Year: 2019

Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology,

In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...

 

Global Digital PCR (d-PCR) Market

Focus on Product-Type, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2020-2025